[{"indications": "Indications\u00a0\n(From 6.1.2.3 Other antidiabetic drugs: British National Formulary)\n6.1.2.3 Other antidiabetic drugs", "name": "SAXAGLIPTIN", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.1 Drugs used in diabetes", "6.1.2 Antidiabetic drugs", "6.1.2.3 Other antidiabetic drugs", "SAXAGLIPTIN"], "cautions": "Cautions\u00a0elderly; determine\r\nrenal function before treatment and periodically thereafter; interactions: Appendix 1 (antidiabetics)", "side-effects": "Side-effects\u00a0vomiting, dyspepsia, gastritis; peripheral oedema;\r\nheadache, dizziness, fatigue; upper respiratory tract infection, urinary\r\ntract infection, gastroenteritis, sinusitis, nasopharyngitis; hypoglycaemia,\r\nmyalgia; less commonly dyslipidaemia, hypertriglyceridaemia,\r\nerectile dysfunction, arthralgia; also reported rash", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/204113.htm", "doses": ["adult over 18 years, 5\u00a0mg\r\nonce daily", "Dose of concomitant sulfonylurea may need\r\nto be reduced"], "pregnancy": "Pregnancy\u00a0avoid unless essential\u2014toxicity in animal studies"}]